The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B
Open accessAbstract
Transcription factors of the NF-kappaB/Rel family are critical for inducible expression of multiple genes involved in inflammatory responses. Sulfasalazine and its salicylate moiety 5-aminosalicylic acid are among the most effective agents for treating inflammatory bowel disease and rheumatoid arthritis. However, the mode of action of these drugs remains unclear. Here we provide evidence that the transcription factor NF-kappaB is a target of sulfasalazine-mediated immunosuppression. Treatment of SW620 colon cells with sulfasalazine inhibited TNFalpha-, LPS-, or phorbol ester- induced NF-kappaB activation. NF-kappaB-dependent transcription was inhibited by sulfasalazine at micro- to millimolar concentrations. In contrast, 5-aminosalicylic acid or sulfapyridine did not block NF-kappaB activation at all doses tested. TNFalpha-induced nuclear translocation of NF-kappaB was prevented by sulfasalazine through inhibition of IkappaBalpha degradation. When blocking proteasome-mediated degradation of IkappaBalpha, we could demonstrate that sulfasalazine interfered with IkappaBalpha phosphorylation, suggesting a direct effect on an IkappaBalpha kinase or on an upstream signal. Inhibition of NF-kappaB activation seems to be specific since other DNA-binding activities such as AP1 were not affected. These results demonstrate that sulfasalazine is a potent and specific inhibitor of NF-kappaB activation, and thus may explain some of the known biological properties of sulfasalazine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intriguingly, sulfasalazine, a drug used for decades to treat autoimmune inflammatory bowel disease (IBD) and psoriatic arthritis (Gupta et al., 1990), is now recognized as targeting the BH4 pathway by inhibiting SPR (Haruki et al., 2013), in addition to other targets, such as NFκB (Wahl et al., 1998).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Wahl et al., 1998
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Schreck, R., RIEBER, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,793
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,002
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Palombella, V. J., Rando, O. J., Goldberg, A. L., & Maniatis, T. (1994) · Cell · doi:10.1016/s0092-8674(94)90482-0 · Cited by 2,089
Structure, Regulation and Function of NF-kappaB
Siebenlist, U. K., Franzoso, G., & Brown, K. D. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.002201 · Cited by 2,086
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E. B., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,744
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,676
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
Schreck, R., Meier, B., Männel, D. N., Dröge, W., & Baeuerle, P. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1181 · Cited by 1,508
Control of IκB-α Proteolysis by Site-Specific, Signal-Induced Phosphorylation
Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., & Siebenlist, U. (1995) · Science · doi:10.1126/science.7878466 · Cited by 1,434
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- [34]34. Chiao, P.J., M. Shigeki, and I.M. Verma. 1994. Autoregulation of I k B a activity. Proc. Natl. Acad. Sci. USA. 91:28-32.
Cited by
Sorted by citations
Items 201–300 of 743
NF-κB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival
Yun, C., Um, H.-R., Jin, Y.-H., Wang, J.-H., Lee, M., Park, S., Lee, J. H., & Cho, H. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00187-8 · Cited by 71
Pountos, I., Giannoudis, P. V., Jones, E., English, A., Churchman, S. M., Field, S. L., Ponchel, F., Bird, H. A., Emery, P., & McGonagle, D. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01006.x · Cited by 71
Lührs, H., Gerke, T., Schauber, J., Dusel, G., Melcher, R., Scheppach, W. M., & Menzel, T. (2001) · International Journal of Colorectal Disease · doi:10.1007/s003840100295 · Cited by 71
Progress in Understanding The Mechanisms of Action of 5-Aminosalicylic Acid
MacDermott, R. P. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02135-3 · Cited by 71
Evolutionarily‐conserved role of the NF‐κB transcription factor in neural plasticity and memory
Romano, A. G., Freudenthal, R., Merlo, E., & Routtenberg, A. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05022.x · Cited by 72
Wakamatsu, K., Nanki, T., Miyasaka, N., Umezawa, K., & Kubota, T. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1834 · Cited by 70
Caerulein-induced NF-κB/Rel activation requires both Ca2+and protein kinase C as messengers
Tando, Y., Algül, H., Wagner, M., Weidenbach, H., Adler, G., & Schmid, R. M. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.3.g678 · Cited by 70
Self-citationHo, L., Juan, T.-Y., Chao, P., Wu, W., Chang, D., Chang, S., & Lai, J. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706000 · Cited by 69
Parhar, K. K. S., Ray, A., Steinbrecher, U. P., Nelson, C. C., & Salh, B. S. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01603.x · Cited by 69
Mendes, A. F., Caramona, M. M., Carvalho, A. P., & Lopes, M. C. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.910104.x · Cited by 68
Lončar, M. B. (2003) · Gut · doi:10.1136/gut.52.9.1297 · Cited by 68
Role of nuclear factor κb in synovial inflammation
Müller‐Ladner, U., Gay, R. E., & Gay, S. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0066-1 · Cited by 66
Neff, L. A., Zeisel, M. B., Sibilia, J., Schöller‐Guinard, M., Klein, J.-P., & Wachsmann, D. (2001) · Cellular Microbiology · doi:10.1046/j.1462-5822.2001.00148.x · Cited by 66
Wong, B. C. Y., JIANG, X. H., Fan, X. M., Lin, M. C. M., Jiang, S. H., Lam, S. K., & Kung, H. F. (2003) · Oncogene · doi:10.1038/sj.onc.1206234 · Cited by 65
Sulfasalazine inhibits activation of nuclear factor‐κB in patients with ulcerative colitis
Gan, H., CHEN, Y., & Ouyang, Q. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03862.x · Cited by 65
Novel sulfasalazine analogues with enhanced NF-kB inhibitory and apoptosis promoting activity
Habens, F., Srinivasan, N., Oakley, F., Mann, D. A., Ganesan, A., & Packham, G. (2005) · APOPTOSIS · doi:10.1007/s10495-005-1877-0 · Cited by 64
Monstad, I., Hovde, Ø., Solberg, I. C., & Moum, B. A. (2014) · Europe PMC (PubMed Central) · Cited by 64
Palazzo, I., Deistler, K., Hoang, T. V., Blackshaw, S., & Fischer, A. J. (2020) · Development · doi:10.1242/dev.183418 · Cited by 60
Cheng, Y. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i3.309 · Cited by 63
Survival ofChlamydia pneumoniae-Infected Mono Mac 6 Cells Is Dependent on NF-κB Binding Activity
Wahl, C., Oswald, F., Simnacher, U., Weiss, S., Marre, R., & Essig, A. (2001) · Infection and Immunity · doi:10.1128/iai.69.11.7039-7045.2001 · Cited by 62
Self-citationBenayoun, B., Baghdiguian, S., Lajmanovich, A., Bartoli, M., Danièle, N., Gicquel, E., Bourg, N., Raynaud, F., Pasquier, M., Suel, L., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8701com · Cited by 62
Platycodin D-induced apoptosis through nuclear factor-κB activation in immortalized keratinocytes
Ahn, K. S., Hahn, B.-S., Kwack, K., Lee, E. B., & Kim, Y. S. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.012 · Cited by 62
Bae, E. M., Kim, W.-J., Suk, K., Kang, Y. M., Park, J.-E., Kim, W. Y., Choi, E. M., Choi, B. K., Kwon, B. S., & Lee, W. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.05.013 · Cited by 62
Alomari, S., Zhang, I., Hernandez, A., Kraft, C. N., Raj, D., Kedda, J. N., & Tyler, B. (2021) · Biomolecules · doi:10.3390/biom11121870 · Cited by 61
Pneumocystis cariniiActivates the NF-κB Signaling Pathway in Alveolar Epithelial Cells
Wang, J., Gigliotti, F., Maggirwar, S. B., Johnston, C. J., Finkelstein, J. N., & Wright, T. W. (2005) · Infection and Immunity · doi:10.1128/iai.73.5.2766-2777.2005 · Cited by 60
Old and New Drugs Used in Rheumatoid Arthritis: A Historical Perspective
Case, J. P. (2001) · American Journal of Therapeutics · doi:10.1097/00045391-200103000-00007 · Cited by 60
Regulation of TRAIL-Induced Apoptosis by Transcription Factors
Göke, R., Göke, A., Göke, B., & Chen, Y. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1650 · Cited by 60
Sugiyama, A., Ohta, T., Obata, M., Takahashi, K., Seino, M., & Nagase, S. (2020) · Oncology Letters · doi:10.3892/ol.2020.11813 · Cited by 61
Park, J., & Cheon, J. H. (2022) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2022.132 · Cited by 59
Gerges, S. H., Tolba, M. F., Elsherbiny, D. A., & El‐Demerdash, E. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13388 · Cited by 58
Anti-inflammatory mediators as physiological and pharmacological regulators of parturition
Rinaldi, S. F., Hutchinson, J. L., Rossi, A. G., & Norman, J. E. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.58 · Cited by 61
Li, Y., Zhang, M., Xiao, H., Fu, H.-B., Ho, A. H. M., Lin, C., Huang, Y., Lin, G., & Bian, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144101 · Cited by 58
Brownfoot, F., Hannan, N. J., Cannon, P., Nguyen, V., Hastie, R. M., Parry, L. J., Senadheera, S. N., Tuohey, L., Tong, S. Y. C., & Kaitu’u‐Lino, T. J. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.02.013 · Cited by 58
Oncology Therapeutics Targeting the Metabolism of Amino Acids
Muhammad, N., Lee, H. M., & Kim, J. (2020) · Cells · doi:10.3390/cells9081904 · Cited by 59
Hämäläinen, M., Lahti, A., & Moilanen, E. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01947-7 · Cited by 57
Haddad, J. J., & Land, S. C. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2607 · Cited by 57
Involvement of Activator Protein-1 in Transcriptional Regulation of the Human μ-Opioid Receptor Gene
Börner, C., Höllt, V., & Kraus, J. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12331-0 · Cited by 56
Bryant, C. E., Farnfield, B. A., & Janicke, H. J. (2003) · American Journal of Veterinary Research · doi:10.2460/ajvr.2003.64.211 · Cited by 56
Linard, C., Grémy, O., & Benderitter, M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.129122 · Cited by 58
Haskó, G., Szabó, C., Németh, Z. H., & Deitch, E. A. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01272.x · Cited by 55
Vry, C. G. D., Prasad, S., Kömüves, L. G., Lorenzana, C., Parham, C. L., Le, T., Adda, S., Hoffman, J., Kahoud, N., Garlapati, R., et al. (2006) · Gut · doi:10.1136/gut.2006.096487 · Cited by 55
Application of Prodrugs to Inflammatory Diseases of the Gut
Oz, H. S., & Ebersole, J. L. (2008) · Molecules · doi:10.3390/molecules13020452 · Cited by 55
Ahmadi, A., Niknahad, H., Li, H., Mobasheri, A., Manthari, R. K., Azarpira, N., Mousavi, K., Khalvati, B., Zhao, Y., Sun, J., et al. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.05.012 · Cited by 54
Singh, K., Chaturvedi, R., Asim, M., Barry, D. P., Lewis, N. D., Vitek, M. P., & Wilson, K. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710530200 · Cited by 54
Wang, J., Gigliotti, F., Bhagwat, S. P., George, T. C., & Wright, T. W. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001058 · Cited by 54
Omata, F., Birkenbach, M. P., Matsuzaki, S., Christ, A. D., & Blumberg, R. S. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200108000-00006 · Cited by 54
Wu, J., Yeung, S. J., Liu, S., Qdaisat, A. Z., Jiang, D., Liu, W., Cheng, Z., Liu, W., Wang, H., Li, L., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00581-9 · Cited by 53
Histone deacetylases, transcriptional control, and cancer
Cress, W. D., & Seto, E. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200007)184:1 · Cited by 624
Okazaki, Y., Sawada, T., Nagatani, K., Komagata, Y., Inoue, T., Muto, S., Itai, A., & Yamamoto, K. (2005) · PubMed · Cited by 53
Inhibitors of poly (ADP-ribose) polymerase modulate signal transduction pathways in colitis
Zingarelli, B., O’Connor, M. P., & Hake, P. W. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01726-6 · Cited by 52
Guidelines for referral and management of systemic lupus erythematosus in adults
Wolfe, F., & Pincus, T. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199909)42:9 · Cited by 269
Kim, J., Cho, H., Sir, J.-J., Kim, B.-K., Hur, J., Youn, S., Yang, H., Jun, S.-I., Park, K. W., Hwang, S., et al. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp072 · Cited by 51
Discovery and development of small molecule modulators targeting glutamine metabolism
Li, L., Meng, Y., Li, Z., Dai, W., Xu, X. J., Xiao-ling, B., & Bian, J. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.066 · Cited by 50
NF-κB as a therapeutic target in autoimmune disease
O’Sullivan, B., Thompson, A., & Thomas, R. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.2.111 · Cited by 51
Targeting NF-κB: A Promising Molecular Therapy in Inflammatory Arthritis
Roman‐Blas, J. A., & Jiménez, S. A. (2008) · International Reviews of Immunology · doi:10.1080/08830180802295740 · Cited by 50
Engineered anti-cancer nanomedicine for synergistic ferroptosis-immunotherapy
Zhang, X., Ge, H., Ma, Y., Song, L., Ma, Y., Tian, G., Wang, L., Meng, Q., & Sun, X. J. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.140688 · Cited by 50
New Ideas for the Prevention and Treatment of Preeclampsia and Their Molecular Inspirations
Sakowicz, A., Bralewska, M., Rybak-Krzyszkowska, M., Grzesiak, M., & Pietrucha, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512100 · Cited by 51
Down-Regulation by Nuclear Factor κB of Human 25-Hydroxyvitamin D3 1α-Hydroxylase Promoter
Ebert, R., Jovanovic, M., Ulmer, M., Schneider, D., Meißner-Weigl, J., Adamski, J., & Jakob, F. J. (2004) · Molecular Endocrinology · doi:10.1210/me.2002-0441 · Cited by 50
An NF-κB and Slug Regulatory Loop Active in Early Vertebrate Mesoderm
Zhang, C., Carl, T. F., Trudeau, E. D., Simmet, T., & Klymkowsky, M. W. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000106 · Cited by 49
Sulfasalazine-induced renal injury in rats and the protective role of thiol-reductants
Heidari, R., Taheri, V., Rahimi, H. R., Yeganeh, B. S., Niknahad, H., & Najibi, A. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1096731 · Cited by 48
Nuclear factor-kappa B inhibitors; a patent review (2006 – 2010)
Kwak, J., Jung, J., & Lee, H. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.638285 · Cited by 48
MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer
Kumari, S., Khan, S., Gupta, S. C., Kashyap, V. K., Yallapu, M. M., Chauhan, S. C., & Jaggi, M. (2018) · Oncogenesis · doi:10.1038/s41389-018-0031-0 · Cited by 48
Biochemical and endocrinological preparation for parturition
Terzidou, V. (2007) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2007.05.001 · Cited by 48
Minamoto, K., Harada, H., Lama, V. N., Fedarau, M. A., & Pinsky, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050377 · Cited by 48
Thapa, D., Lee, J. S., Park, S., Bae, Y.-H., Bae, S., Kwon, J. B., Kim, K. J., Kwak, M., Park, Y., Choi, H. G., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141887 · Cited by 48
Keelan, J. A., Khan, S., Yosaatmadja, F., & Mitchell, M. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802660 · Cited by 47
Lee, M.-Y., Kim, W.-J., Kang, Y., Jung, Y., Kang, Y. M., Suk, K., Park, J.-E., Choi, E.-M., Choi, B.-K., Kwon, B. S., et al. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306160 · Cited by 47
Resolving fibrosis in the diseased liver: Translating the scientific promise to the clinic
Muddu, A. K., Guha, I. N., Elsharkawy, A. M., & Mann, D. A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.10.006 · Cited by 46
Tuğcu, V., Özbek, E., Taşçı, A. İ., Kemahlı, E., Somay, A., Baş, M., Karaca, Ç., Altuğ, T., Çekmen, M., & Ozdogan, H. K. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06321.x · Cited by 46
Chikaraishi, A., Hirahashi, J., Takase, O., Marumo, T., Hishikawa, K., Hayashi, M., & Saruta, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01215-8 · Cited by 46
The Effect of Sulfasalazine on Rheumatoid Arthritic Synovial Tissue Chemokine Production
Volin, M. V., Campbell, P. L., Connors, M. A., Woodruff, D. C., & Koch, A. E. (2002) · Experimental and Molecular Pathology · doi:10.1006/exmp.2002.2460 · Cited by 46
Fichorova, R. N., Zhou, F., Ratnam, V., Atanassova, V., Jiang, S., Strick, N., & NEURATH, A. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.323-335.2005 · Cited by 46
Choi, J., Kim, J.-A., Kim, D., Chun, M.-H., Gwag, B. J., Yoon, S. K., & Joo, C.-K. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02886-9 · Cited by 46
Kim, M. S., Lim, W. K., Park, R., Shin, T., Yoo, Y.-H., Hong, S., An, N., & Kim, H. M. (2005) · Cytokine · doi:10.1016/j.cyto.2005.10.001 · Cited by 46
Scott, B. B., Zaratin, P., Gilmartin, A. G., Hansbury, M., Colombo, A., Belpasso, C., Winkler, J., & Jackson, J. R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.180 · Cited by 46
Butyrate Inhibits Interleukin-1-Mediated Nuclear Factor-Kappa B Activation in Human Epithelial Cells
Lührs, H., Gerke, T., Boxberger, F., Backhaus, K., Melcher, R., Scheppach, W. M., & Menzel, T. P. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1010699418024 · Cited by 46
Induction of the stress response with prostaglandin A 1 increases I‐κBα gene expression
Thomas, S. C., Ryan, M. A., Shanley, T. P., & Wong, H. R. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.13.1371 · Cited by 46
Malhotra, V., Shanley, T. P., Pittet, J., Welch, W. J., & Wong, H. R. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.1.4384 · Cited by 45
Expression and regulation of glutathione S-transferase P1-1 in cultured human epidermal cells
Zhang, Y., Gonzalez-Pena, V., & Xu, M. J. (2002) · Journal of Dermatological Science · doi:10.1016/s0923-1811(02)00107-x · Cited by 45
Targeting ferroptosis in melanoma: cancer therapeutics
Khorsandi, K., Esfahani, H., Keyvani‐Ghamsari, S., & lakhshehei, P. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01296-w · Cited by 48
Liu, Q., Wu, H., Chim, S. M., Zhou, L., Zhao, J., Feng, H., Wei, Q., Wang, Q., Zheng, M., Tan, R. X., et al. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.09.017 · Cited by 44
Wiese, M. D., Schnabl, M., O’Doherty, C., Spargo, L. D., Sorich, M. J., Cleland, L. G., & Proudman, S. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3911 · Cited by 44
He, T., Liu, S., Chen, S., Ye, J., Wu, X., Bian, Z., & Chen, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01556 · Cited by 44
Egan, L. J., & Törüner, M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.009 · Cited by 44
Molecular mechanisms of sulfasalazine‐induced T‐cell apoptosis
Liptay, S., Fulda, S., Schanbacher, M., Bourteele, S., Ferri, K. F., Kroemer, G., Adler, G., Debatin, K., & Schmid, R. M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704870 · Cited by 44
Self-citationTherapeutic Targets for Hypoxia-Elicited Pathways
Taylor, C. T., & Colgan, S. P. (1999) · Pharmaceutical Research · doi:10.1023/a:1011936016833 · Cited by 44
Medical Therapy for Crohn's Disease
Stein, R. B., & Lichtenstein, G. R. (2001) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70274-7 · Cited by 44
Duan, C., Liu, Y., Li, Y., Chen, H., Liu, X., Chen, X., Yue, J., Zhou, X., & Yang, J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.06.028 · Cited by 44
Kollander, R., Solovey, A. N., Milbauer, L. C., Abdulla, F. A., Kelm, R. J., & Hebbel, R. P. (2009) · Translational research · doi:10.1016/j.trsl.2009.10.004 · Cited by 43
Lallemend, F., Hadjab, S., Hans, G. A., Moonen, G., Lefebvre, P. P., & Malgrange, B. (2005) · Journal of Cell Science · doi:10.1242/jcs.02572 · Cited by 43
Hyperoxia synergistically increases TNF-α-induced interleukin-8 gene expression in A549 cells
Allen, G. L., Menendez, I. Y., Ryan, M. A., Mazor, R. L., Wispé, J. R., Fiedler, M. A., & Wong, H. R. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.278.2.l253 · Cited by 43
Wine, E., Aloi, M., Biervliet, S. V., Bronský, J., de Carpi, J. M., Gasparetto, M., Gianolio, L., Gordon, H., Hojsak, I., Hudson, A. S., et al. (2025) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.70097 · Cited by 52
Brégégère, F. M., Milner, Y., & Friguet, B. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.09.002 · Cited by 43
Munkholm, P. S., Loftus, E. V., Reinacher‐Schick, A., Kornbluth, A. A., Mittmann, U., & Esendal, B. (2006) · Digestion · doi:10.1159/000090763 · Cited by 42
Sheldrick, E. L., Derecka, K., Marshall, E., Chin-Smith, E. C., Hodges, L., Wathes, D. C., Abayasekara, D. R. E., & Flint, A. P. F. (2007) · Biochemical Journal · doi:10.1042/bj20070089 · Cited by 40
Zer, C., Sachs, G. M., & Shin, J. M. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00080.2007 · Cited by 41
Jeon, S., Kim, W., Lee, S., Lee, M. Y., Park, S., Lee, S., Kim, I., Suk, K., Choi, B. K., Choi, E. M., et al. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.75 · Cited by 41
Indications for 5-aminosalicylate in inflammatory bowel disease: Is the body of evidence complete
Bodegraven, A. A. V. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i38.6115 · Cited by 41
Lee, S., Oh, P., Ko, J., Lim, K., & Lim, K.-T. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0850-x · Cited by 41
Ilowite, N. T., & Laxer, R. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6581-4.10006-8 · Cited by 41
Metadata
- Authors
- Wahl, C., Liptay, S., Adler, G., & Schmid, R. M.
- Affiliations
- Universität Ulm (DE)
- Corresponding author
- Schmid, R M
- ORCID
- Schmid, R M
- Venue
- Journal of Clinical Investigation
- Published
- 1998-03-01
- Volume
- 101
- Issue
- 5
- Pages
- 1163-1174
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508669
- OpenAlex
- W2011496352
- Cited by
- 742
- References
- 48
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 17 · 2023: 18 · 2022: 18 · 2021: 26 · 2020: 15 · 2019: 18 · 2018: 19 · 2017: 11 · 2016: 15 · 2015: 19 · 2014: 17 · 2013: 24 · 2012: 19
- FWCI
- 17.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- sulfasalazine, NF-κB, IκBα degradation, IκBα phosphorylation, IκBα kinase, NF-κB nuclear translocation, 5-aminosalicylic acid, sulfapyridine, TNF-α, LPS, phorbol ester, proteasome, AP-1, immunosuppression, inflammatory bowel disease, rheumatoid arthritis, colon cancer cells
- MeSH terms
- Anti-Infective Agents, Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal, Antioxidants, Aspirin, Cells, Cultured, Colonic Diseases, Cystine, Epithelial Cells, Humans, Immunosuppression Therapy, Lipopolysaccharides, Phorbol Esters, Phosphorylation, Plasmids, Proline, Recombinant Proteins, Recombination, Genetic, Sulfasalazine, Sulfapyridine, Thiocarbamates, Transfection, Tumor Necrosis Factor-alpha, Blotting, Western, NF-kappa B, Transcription Factor AP-1, Fluorescent Antibody Technique, Indirect, Mesalamine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review